Voluntary workplace genomic testing: wellness benefit or Pandora's box?

Voluntary workplace genomic testing: wellness benefit or Pandora's box?
复制标题

DOI:
10.1038/s41525-021-00276-8
复制
发表时间:
2022-01-20
影响因子:
5.3
通讯作者:
Mathews DJH
Mathews DJH
中科院分区:
医学2区
文献类型:
--
作者:
Sanghavi K;Cohn B;Prince AER;Feero WG;Ryan KA;Spector-Bagdady K;Uhlmann WR;Lee C;Roberts JS;Mathews DJH

文献摘要

参考文献

被引文献

相似文献

消费者对基因和基因组检测的兴趣正在迅速增长,超过2600万美国人购买了直接面向消费者的基因检测服务。利用消费者对临床环境之外的基因检测越来越满意,商业供应商正在通过向雇主营销基因和基因组检测服务(包括药物基因组学和致病性变体检测)来扩大其客户群,以纳入工作场所健康计划。我们描述了自愿工作场所基因检测(wGT)的雇主和雇员的吸引力,如何在道德,法律的和社会影响的文献已经接近的问题,在过去的工作场所基因检测,并概述了相关的法律的景观。鉴于我们正处于wGT市场发展的早期阶段,现在是确定员工和雇主的关键利益和关注点的时候了,这样治理就可以沿着wGT市场发展和演变,而不是落后于它,并基于数据,而不是投机性的希望和恐惧。
Consumer interest in genetic and genomic testing is growing rapidly, with more than 26 million Americans having purchased direct-to-consumer genetic testing services. Capitalizing on the increasing comfort of consumers with genetic testing outside the clinical environment, commercial vendors are expanding their customer base by marketing genetic and genomic testing services, including testing for pharmacogenomic and pathogenic variants, to employers for inclusion in workplace wellness programs. We describe the appeal of voluntary workplace genomic testing (wGT) to employers and employees, how the ethical, legal, and social implications literature has approached the issue of genetic testing in the workplace in the past, and outline the relevant legal landscape. Given that we are in the early stages of development of the wGT market, now is the time to identify the critical interests and concerns of employees and employers, so that governance can develop and evolve along with the wGT market, rather than behind it, and be based on data, rather than speculative hopes and fears.
DOI: 10.2190/ns.21.1.j
发表时间: 2011-05-01
影响因子: 2.3
作者:
Brandt-Rauf, Sherry, I;Brandt-Rauf, Elka;Brandt-Rauf, Paul W.
通讯作者: Brandt-Rauf, Paul W.
DOI: 10.1038/gim.2013.11
发表时间: 2013-05
期刊: Genetics in medicine : official journal of the American College of Medical Genetics
影响因子: --
作者:
Evans JP;Berg JS;Olshan AF;Magnuson T;Rimer BK
通讯作者: Rimer BK
DOI: 10.1080/19325037.2012.10599239
发表时间: 2012-01-01
影响因子: 1
作者:
Hui, Siu-kuen Azor;Engelman, Kimberly;Ellerbeck, Edward F.
通讯作者: Ellerbeck, Edward F.
DOI: 10.1057/s41292-017-0064-1
发表时间: 2018-03-01
期刊: BIOSOCIETIES
影响因子: 1.6
作者:
Hull, Gordon;Pasquale, Frank
通讯作者: Pasquale, Frank
DOI: 10.1097/00043764-198109000-00011
发表时间: 1981-01-01
影响因子: 3.2
作者:
DABNEY, BJ
通讯作者: DABNEY, BJ